155 related articles for article (PubMed ID: 3825999)
21. [Prognostic value of the ratio of bone marrow plasma cells in multiple myeloma].
Pasqualetti P; Colantonio D; Casale R
Minerva Med; 1990 Mar; 81(3):129-33. PubMed ID: 2320280
[TBL] [Abstract][Full Text] [Related]
22. Stage III multiple myeloma: clinical and prognostic value of spinal bone marrow MR imaging.
Lecouvet FE; Vande Berg BC; Michaux L; Malghem J; Maldague BE; Jamart J; Ferrant A; Michaux JL
Radiology; 1998 Dec; 209(3):653-60. PubMed ID: 9844655
[TBL] [Abstract][Full Text] [Related]
23. [Evaluation of a morphologic staging method (myeloma progression score) in multiple myeloma].
Pasqualetti P; Casale R; Collacciani A; Colantonio D
Medicina (Firenze); 1989; 9(3):280-2. PubMed ID: 2615598
[TBL] [Abstract][Full Text] [Related]
24. [Prognostic and therapeutic significance of bone marrow biopsy in multiple myeloma. Analysis of 31 stage II A and III A patients].
Paule B; Quillard J; Medicis P; Bourgeois P; Grossin M; Bisson M; Kahn MF
Rev Rhum Mal Osteoartic; 1988 Jan; 55(1):27-32. PubMed ID: 3353673
[TBL] [Abstract][Full Text] [Related]
25. [Prognostic soundness of the cytologic and histologic examination of the bone marrow in myeloma].
Bettini R; Rapazzini P; Ferrari V; Ambruzzi AM; Mascalzi MG; Steidl L
Recenti Prog Med; 1986; 77(7-8):357-61. PubMed ID: 3786936
[No Abstract] [Full Text] [Related]
26. Clinical significance of bone marrow biopsy and plasma cell morphology in MM and MGUS.
Bartl R; Frisch B
Pathol Biol (Paris); 1999 Feb; 47(2):158-68. PubMed ID: 10192882
[TBL] [Abstract][Full Text] [Related]
27. Correlation Between Baseline 18F-FDG PET/CT Findings and CD38- and CD138-Expressing Myeloma Cells in Bone Marrow and Clinical Parameters in Patients with Multiple Myeloma.
Cengiz A; Arda HÜ; Döğer F; Yavaşoğlu İ; Yürekli Y; Bolaman AZ
Turk J Haematol; 2018 Aug; 35(3):175-180. PubMed ID: 29806594
[TBL] [Abstract][Full Text] [Related]
28. [Morphologic and clinical study of 131 cases of plasma cell myeloma].
Chen HS; Liu EB; Wang TT; Yang RC; Fang LH; Yang QY; Gao JY; Yu MH; Qian LS
Zhonghua Bing Li Xue Za Zhi; 2004 Feb; 33(1):44-8. PubMed ID: 14989928
[TBL] [Abstract][Full Text] [Related]
29. [Prognostic evaluation in multiple myeloma. Relationship between immunological types, single prognostic factors, clinical staging systems, morphological classification systems and survival].
Pasqualetti P; Colantonio D; Casale R; Di Lauro G; Collacciani A; Festuccia V; Trotta A; Natali G
Ann Ital Med Int; 1990; 5(3 Pt 1):195-204. PubMed ID: 2288822
[TBL] [Abstract][Full Text] [Related]
30. Stage I multiple myeloma: value of MR imaging of the bone marrow in the determination of prognosis.
Van de Berg BC; Lecouvet FE; Michaux L; Labaisse M; Malghem J; Jamart J; Maldague BE; Ferrant A; Michaux JL
Radiology; 1996 Oct; 201(1):243-6. PubMed ID: 8816551
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of stratification systems in multiple myeloma. II. Clinical staging systems.
Scudla V; Indrák K
Neoplasma; 1985; 32(4):481-93. PubMed ID: 4047259
[TBL] [Abstract][Full Text] [Related]
32. [Prognostic clinical and morphological classification of multiple myeloma (author's transl)].
Wutke K; Rüdiger KD; Kelényi G
Arch Geschwulstforsch; 1979; 49(8):671-84. PubMed ID: 543783
[TBL] [Abstract][Full Text] [Related]
33. [The prognostic significance of cytological study of the bone marrow in multiple myeloma].
Iakovleva SV
Ter Arkh; 2000; 72(7):48-51. PubMed ID: 10983321
[TBL] [Abstract][Full Text] [Related]
34. Cytological and histological classification of multiple myeloma.
Wutke K; Várbíró M; Rüdiger KD; Kelényi G
Haematologia (Budap); 1981; 14(3):315-29. PubMed ID: 7327443
[TBL] [Abstract][Full Text] [Related]
35. Plasma cell myeloma with cleaved, multilobated, and monocytoid nuclei.
Zukerberg LR; Ferry JA; Conlon M; Harris NL
Am J Clin Pathol; 1990 May; 93(5):657-61. PubMed ID: 2183587
[TBL] [Abstract][Full Text] [Related]
36. [Analysis of the international staging system of multiple myeloma and its comparison with the DS and IFM staging system in 122 Chinese patients].
Deng SH; Xu Y; Mai YJ; Wang YF; Zhao YZ; Zou DH; Qiu LG
Zhonghua Xue Ye Xue Za Zhi; 2008 Apr; 29(4):217-21. PubMed ID: 18843972
[TBL] [Abstract][Full Text] [Related]
37. 99mTc-sestamibi imaging and bone marrow karyotyping in the assessment of multiple myeloma and MGUS.
Giovanella L; Taborelli M; Ceriani L; Zucca E; Cavalli F; Delaloye AB
Nucl Med Commun; 2008 Jun; 29(6):535-41. PubMed ID: 18458600
[TBL] [Abstract][Full Text] [Related]
38. A Comparison of Different Staging Systems for Multiple Myeloma: Can the MRI Pattern Play a Prognostic Role?
Filonzi G; Mancuso K; Zamagni E; Nanni C; Spinnato P; Cavo M; Fanti S; Salizzoni E; Bazzocchi A
AJR Am J Roentgenol; 2017 Jul; 209(1):152-158. PubMed ID: 28418695
[TBL] [Abstract][Full Text] [Related]
39. Imaging findings and clinical features of patients with multiple myeloma with the prognostic effect of bone marrow focal and diffuse infiltration patterns on spine MRI.
Aribas BK; Arda K; Yologlu Z; Ciledag N; Aktas E; Ozdemir S; Dogan K; Fen T; Dagli M
Minerva Med; 2011 Apr; 102(2):115-24. PubMed ID: 21483398
[TBL] [Abstract][Full Text] [Related]
40. [Therapeutic application of sequential bone marrow biopsy in myeloma: analysis of 13 medullary biopsies].
Paule B; Médicis P; Clerc D; Bennet P; Bisson M; Massias P
Biomed Pharmacother; 1986; 40(7):261-4. PubMed ID: 3814757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
